Tianjian Group (000090): High-quality projects enter the carry-over period of the Bay Area and national reforms trying to boost estimates The company’s high-quality projects have entered the carry-over period, and the short-term performance flexibility is guaranteed; the shareholder controlling shareholder Shenzhen SASAC…
read moreYangtze Power (600900) 2019 Semi-annual Report Commentary: Performance in line with expectations, strengthened investment layout 2019H1 revenue increased by 6%, and net profit attributable to mother increased by 1%. The company’s 2019H1 revenue +6.00% to 203.6.3 billion, net profit attributable to mother…
read moreYabao Pharmaceutical (600351) Commentary Report: Both the annual growth report and the first quarterly report of the core varieties benefited from the rapid growth of over 30% Event: The company released its 2018 annual report and gradually realized revenue29. 1.8 billion (+14….
read moreVanke A (000002) November 2019 sales data review: Sales are temporarily weak and cautious Vanke announced the company’s November sales data, and the company’s contracted amount in November was 545. 400 million, down 6 every year. 5%; Achieve contracted area of 364….
read moreThe average daily turnover of the first technology ETF reached 5.75 billion tops all ETF themes Source: Huabao Fund Original title: The average daily turnover of the first technology leader ETF is as high as 5.US $ 7.5 billion, ranking first among…
read moreWHO Director catches outbreak window period Xinhua News Agency, February 4th (Reporter Ling Xin and Chen Junxia) The Director General of the World Health Organization Tan Desai urged relevant countries to seize the window of epidemic prevention and control and to share…
read moreRongsheng Development (002146) Quarterly Commentary: Stable Performance Growth, Short-term Debt Repayment Pressure Rising The performance growth was stable, and the gross profit margin of the settlement in the third quarter improved. In the first three quarters of 19 years ago, the company…
read moreHaixiang Pharmaceutical (002099): The underrated leader in domestic pharmaceutical raw materials Medicine and dyes are the core business modules of Haixiang Pharmaceutical. The company went public in 2006. After the implementation of major asset reorganization in 2014, a two-wheel drive development model…
read moreAVIC Optoelectronics (002179): Performance in line with expectations Firmly optimistic military white horse adds 5G new kinetic energy Event description The company released its semi-annual report for 2019: 佛山桑拿网 the company achieved operating income of 45 in the first half of 2019….
read moreDepth * Company * Hytera (002583): Comprehensive performance restoration, R & D, and future growth In 2018, the company achieved operating income of 69. 35 ppm, an increase of 29 in ten years. 58%; net profit attributable to mother is 4. 770,000…
read more